AU2021331487A1 - Methods for the treatment of cardiovascular disease with cyclodextrins - Google Patents

Methods for the treatment of cardiovascular disease with cyclodextrins Download PDF

Info

Publication number
AU2021331487A1
AU2021331487A1 AU2021331487A AU2021331487A AU2021331487A1 AU 2021331487 A1 AU2021331487 A1 AU 2021331487A1 AU 2021331487 A AU2021331487 A AU 2021331487A AU 2021331487 A AU2021331487 A AU 2021331487A AU 2021331487 A1 AU2021331487 A1 AU 2021331487A1
Authority
AU
Australia
Prior art keywords
administering
amount
therapeutically effective
cyclodextrin
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021331487A
Other languages
English (en)
Inventor
Jason CAMM
Diana KERWIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beren Therapeutics PBC
Original Assignee
Beren Therapeutics PBC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beren Therapeutics PBC filed Critical Beren Therapeutics PBC
Publication of AU2021331487A1 publication Critical patent/AU2021331487A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2021331487A 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins Abandoned AU2021331487A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
US63/071,257 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (1)

Publication Number Publication Date
AU2021331487A1 true AU2021331487A1 (en) 2023-03-16

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021331487A Abandoned AU2021331487A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Country Status (14)

Country Link
US (2) US20240000826A1 (https=)
EP (1) EP4203974A4 (https=)
JP (1) JP2023543131A (https=)
KR (1) KR20230104119A (https=)
CN (1) CN116322644A (https=)
AU (1) AU2021331487A1 (https=)
CA (1) CA3189915A1 (https=)
CO (1) CO2023003656A2 (https=)
CR (1) CR20230135A (https=)
IL (1) IL300805A (https=)
JO (1) JOP20230043A1 (https=)
MX (1) MX2023002418A (https=)
PE (1) PE20231169A1 (https=)
WO (1) WO2022047249A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
CN104244956B (zh) * 2012-04-13 2020-04-17 L&F研究有限公司 使用环糊精的方法

Also Published As

Publication number Publication date
US20240000826A1 (en) 2024-01-04
CO2023003656A2 (es) 2023-08-09
WO2022047249A1 (en) 2022-03-03
CA3189915A1 (en) 2022-03-03
JOP20230043A1 (ar) 2023-02-27
MX2023002418A (es) 2023-07-11
JP2023543131A (ja) 2023-10-13
CN116322644A (zh) 2023-06-23
US20230091966A1 (en) 2023-03-23
IL300805A (en) 2023-04-01
CR20230135A (es) 2023-07-19
PE20231169A1 (es) 2023-07-26
EP4203974A4 (en) 2024-08-07
KR20230104119A (ko) 2023-07-07
EP4203974A1 (en) 2023-07-05

Similar Documents

Publication Publication Date Title
JP7835735B2 (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
KR20130026504A (ko) 트롬복산-a2 수용체 길항제를 이용한 간신증후군 및 간성뇌증의 치료방법
US20240082242A1 (en) Combination therapies
US20230091966A1 (en) Methods for the treatment of cardiovascular disease with cyclodextrins
CN119212693A (zh) 用于治疗肌萎缩性侧索硬化的牛磺酸二醇和苯丁酸钠的组合
US20240398849A1 (en) Methods for the treatment of hypertriglyceridemia with cyclodextrins
US20230375576A1 (en) Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
US20230302042A1 (en) Methods for the prevention of cholesterol crystal embolization with cyclodextrins
CN104507478A (zh) 用于治疗急性冠状动脉综合征的烟酰胺衍生物
TWI552748B (zh) The use of a compound for the removal of hepatotoxicity against Acetaminophen (APAP)
JP2023547633A (ja) 脂肪肝の治療及び／又は予防のためのメチルシクロデキストリンを含む組成物
JPWO2007123126A1 (ja) 慢性心不全における運動耐容能低下の改善剤

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period